Robert Szulkin

3.3k total citations
25 papers, 617 citations indexed

About

Robert Szulkin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Robert Szulkin has authored 25 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Robert Szulkin's work include Breast Cancer Treatment Studies (6 papers), Global Cancer Incidence and Screening (5 papers) and HER2/EGFR in Cancer Research (3 papers). Robert Szulkin is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Global Cancer Incidence and Screening (5 papers) and HER2/EGFR in Cancer Research (3 papers). Robert Szulkin collaborates with scholars based in Sweden, United States and Denmark. Robert Szulkin's co-authors include Jana de Boniface, Anna L.V. Johansson, Per Wändell, Märit Mejhert, Gunnar Ljunggren, Thomas Kahan, Björn Wettermark, Kristina Sundquist, Marilyn A. Winkleby and Lars Skog and has published in prestigious journals such as PLoS ONE, The Lancet Oncology and International Journal of Epidemiology.

In The Last Decade

Robert Szulkin

24 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Szulkin Sweden 11 193 139 101 98 72 25 617
Liu He China 16 311 1.6× 60 0.4× 137 1.4× 55 0.6× 42 0.6× 79 828
Yunji Hwang South Korea 17 100 0.5× 70 0.5× 137 1.4× 173 1.8× 40 0.6× 30 825
Alice R Carter United Kingdom 10 130 0.7× 56 0.4× 106 1.0× 32 0.3× 73 1.0× 23 1.0k
Yuan Yang China 18 209 1.1× 86 0.6× 115 1.1× 202 2.1× 19 0.3× 41 851
Astrid Fink Germany 16 86 0.4× 33 0.2× 135 1.3× 168 1.7× 23 0.3× 60 958
In Young Cho South Korea 13 88 0.5× 34 0.2× 60 0.6× 78 0.8× 46 0.6× 82 619
Dominique Lejeune United States 14 114 0.6× 32 0.2× 52 0.5× 106 1.1× 49 0.7× 64 570
Signe Benzon Larsen Denmark 19 46 0.2× 172 1.2× 103 1.0× 324 3.3× 52 0.7× 54 871
Indra Tumur United Kingdom 11 58 0.3× 79 0.6× 245 2.4× 90 0.9× 15 0.2× 11 812
Sanni Ruotsalainen Finland 12 132 0.7× 55 0.4× 103 1.0× 23 0.2× 31 0.4× 26 765

Countries citing papers authored by Robert Szulkin

Since Specialization
Citations

This map shows the geographic impact of Robert Szulkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Szulkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Szulkin more than expected).

Fields of papers citing papers by Robert Szulkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Szulkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Szulkin. The network helps show where Robert Szulkin may publish in the future.

Co-authorship network of co-authors of Robert Szulkin

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Szulkin. A scholar is included among the top collaborators of Robert Szulkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Szulkin. Robert Szulkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Tvedskov, Tove Filtenborg, Robert Szulkin, Sara Alkner, et al.. (2024). Axillary clearance and chemotherapy rates in ER+HER2− breast cancer: secondary analysis of the SENOMAC trial. The Lancet Regional Health - Europe. 47. 101083–101083. 1 indexed citations
4.
Bower, Hannah, Paul W. Dickman, Anna Ravn Landtblom, et al.. (2022). Modelling multiple time-scales with flexible parametric survival models. BMC Medical Research Methodology. 22(1). 290–290. 2 indexed citations
5.
Møller, Axel, Klaus Schwamborn, Janet Hoogstraate, et al.. (2022). Travel vaccines are strongly associated to reduced mortality in prostate cancer patients - a real effect or residual confounding?. Vaccine. 40(27). 3797–3801. 1 indexed citations
6.
Fröberg, Gabrielle, Margarida Correia‐Neves, Robert Szulkin, et al.. (2020). CD4+ T cell proliferative responses to PPD and CFP-10 associate with recent M. tuberculosis infection. Tuberculosis. 123. 101959–101959. 3 indexed citations
9.
Falato, Claudette, Sara Taylor, Robert Szulkin, et al.. (2018). Prognosis in patients diagnosed with loco-regional failure of breast cancer: 34 years longitudinal data from the Stockholm–Gotland cancer registry. Breast Cancer Research and Treatment. 172(3). 703–712. 4 indexed citations
10.
Szulkin, Robert, Mark Clements, Patrik K. E. Magnusson, Fredrik Wiklund, & Ralf Kuja‐Halkola. (2017). Estimating Heritability of Prostate Cancer‐Specific Survival Using Population‐Based Registers. The Prostate. 77(8). 900–907. 3 indexed citations
11.
Åsberg, Marie, Åke Nygren, Robert Szulkin, et al.. (2016). Possible Biomarkers of Chronic Stress Induced Exhaustion - A Longitudinal Study. PLoS ONE. 11(5). e0153924–e0153924. 15 indexed citations
12.
Orrevall, Ylva, et al.. (2015). Evaluation of a continuing educational intervention for primary health care professionals about nutritional care of patients at home. The journal of nutrition health & aging. 20(4). 428–438. 12 indexed citations
13.
Bonn, Stephanie E., Fredrik Wiklund, Arvid Sjölander, et al.. (2015). Body Mass Index and Weight Change in Men with Prostate Cancer: Progression and Mortality.. International Journal of Epidemiology. 44(suppl_1). i141–i142. 2 indexed citations
14.
Wettermark, Björn, Per Wändell, Märit Mejhert, et al.. (2013). The Epidemiology of Heart Failure, Based on Data for 2.1 Million Inhabitants in Sweden. European Journal of Heart Failure. 15(9). 995–1002. 222 indexed citations
15.
Nager, Anna, et al.. (2012). High lifelong relapse rate of psychiatric disorders among women with postpartum psychosis. Nordic Journal of Psychiatry. 67(1). 53–58. 18 indexed citations
16.
Andréasson, Anna, et al.. (2012). Inflammation and positive affect are associated with subjective health in women of the general population. Journal of Health Psychology. 18(3). 311–320. 36 indexed citations
17.
Szulkin, Robert, Erik Holmberg, Pär Stattin, et al.. (2011). Prostate cancer risk variants are not associated with disease progression. The Prostate. 72(1). 30–39. 13 indexed citations
18.
Kawakami, Naomi, Marilyn A. Winkleby, Lars Skog, Robert Szulkin, & Kristina Sundquist. (2010). Differences in neighborhood accessibility to health-related resources: A nationwide comparison between deprived and affluent neighborhoods in Sweden. Health & Place. 17(1). 132–139. 50 indexed citations
19.
Andréasson, Anna, Susanna Jernelöv, Robert Szulkin, et al.. (2010). Associations between leptin and self-rated health in men and women. Gender Medicine. 7(3). 261–269. 6 indexed citations
20.
Reilly, Marie & Robert Szulkin. (2007). Statistical analysis of donation–transfusion data with complex correlation. Statistics in Medicine. 26(30). 5572–5585. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026